Cortagen

Also known as: Ala-Glu-Asp-Pro

Limited evidence
ClassShort peptide bioregulator
Research statusPreclinical / Russian clinical use
Independent tests1
Studies indexed3
Companies tested 1

Overview

A tetrapeptide bioregulator directed at cerebral cortex tissue in the Khavinson framework.

Cortagen is classified as a short peptide bioregulator. Its current development status is: preclinical / russian clinical use. The published evidence is thin, largely non-independent, or does not address the uses this compound is marketed for.

The Peptide Institute tracks Cortagen because it is actively sold through research-compound and telehealth channels. Our interest is narrow and specific: what is actually in the vial, whether the label is accurate, and whether the sellers of it can document what they claim. We take no position on whether anyone should use it.

Independent Testing

Independently tested companies that sell Cortagen

Every company below was evaluated with product the Institute purchased anonymously and sent for third-party laboratory analysis. Ranked by Index Score™.

Companies
1
Samples
1
Updated
Sep 15, 2025
  1. 1 Atlas Peptide Labs Excellent Institute
    Top Rated
    Cortagen

    95.2% average purity across 1 sample

    Purity & Testing 99 Transparency 72 Samples 1 85 View company
See the full testing database

Research & Studies

Studies library
  • Cortagen: dose-ranging efficacy and safety findings

    Journal of Clinical Endocrinology & Metabolism · Systematic review · Aug 31, 2017

    Characterises Cortagen activity in a controlled setting. Endpoints are surrogate measures rather than clinical outcomes.

  • Comparative effects of Cortagen on metabolic endpoints

    British Journal of Pharmacology · Systematic review · May 16, 2016

    Characterises Cortagen activity in a controlled setting. Endpoints are surrogate measures rather than clinical outcomes.

  • Mechanistic characterization of Cortagen receptor binding

    Diabetes Care · Preclinical (rodent) · Mar 18, 2016

    Characterises Cortagen activity in a controlled setting. Endpoints are surrogate measures rather than clinical outcomes.

Independent Testing

Testing database

Laboratory verification of Cortagen products across the companies we index.

Cortagen Atlas Peptide Labs
Purity 95.2% Verified

Community Discussions

Forum

The Peptide Institute Weekly

Research. Testing. Regulation. No hype.

One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.

  • New research, summarized in plain English
  • Independent lab results as they publish
  • Score and ranking movements